Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-29

FDA Approved: RILPIVIRINE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original application for rilpivirine (RILPIVIRINE) as a generic product from Somerset Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rilpivirine (rilpivirine)

Snippet

ORIG AP for RILPIVIRINE (RILPIVIRINE)